Results 151 to 160 of about 3,005,108 (342)

Late Toxicity and Long‐Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi‐National Study

Head &Neck, EarlyView.
ABSTRACT Background Because salivary gland cancers (SGC) are rare and include different tumor subtypes, data on their long‐term quality of life and late toxicities are sparse. Methods Multi‐national study including SGC survivors more than 5 years after diagnosis.
Susanne Singer, Cecilie Delphin Amdal, Kristin Bjordal, Bente Brokstad Herlofson, Guro Lindviksmoen Astrup, Andreas Boehm, Ulrike Wöhner, Eva Hammerlid, Ricardo Ribeiro Gama, Alexandre Arthur Jacinto, Femke Jansen, Irma Verdonck de Leeuw, Tatiana Dragan, Fréderic Duprez, Naomi Kiyota, Monica Pinto, Maximilian Krüger, Orlando Guntinas‐Lichius, Johanna Inhestern, Francesco Tramacere, Pierluigi Bonomo, Giuseppe Fanetti, Sandra Nuyts, Michaela Plath, Noa Stempler, Kristine Løken Westgaard, Katherine J. Taylor   +26 more
wiley   +1 more source

Pancreaticoduodenectomy for selected periampullary neuroendocrine tumors: Fifty patients

, 1997
Giao Q. Phan, Charles J. Yeo, John L. Cameron, Michael M. Maher, Ralph H. Hruban, Robert Udelsman   +5 more
openalex   +1 more source

Myosin XVA Expression in the Pituitary and in Other Neuroendocrine Tissues and Tumors [PDF]

, 2001
Ricardo V. Lloyd, Sergio Vidal, Long Jin, Shuya Zhang, Kálmán Kovács, Éva Horváth, Bernd W. Scheithauer, Erich T. Boger, Robert A. Fridell, Thomas B. Friedman   +9 more
openalex   +1 more source

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

Neuroendocrinology, 2016
M. Falconi, B. Eriksson, G. Kaltsas, D. Bartsch, J. Capdevila, M. Caplin, B. Kos-Kudła, D. Kwekkeboom, G. Rindi, G. Klöppel, N. Reed, R. Kianmanesh, R. Jensen   +12 more
semanticscholar   +1 more source

Gastrointestinal neuroendocrine tumors

Annals of Oncology, 2010
Gastrointestinal neuroendocrine tumors (GI-NETs) are a genetically diverse group of malignancies that sometimes produce peptides causing characteristic hormonal syndromes. NETs can be clinically symptomatic (functioning) or silent (non-functioning); both types frequently synthesize more than one peptide, although often these are not associated with ...
openaire   +3 more sources

Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution

International Journal of Cancer, EarlyView.
Abstract Prostate cancer is a common malignancy that in 5%–30% leads to treatment‐resistant and highly aggressive disease. Metastasis‐potential and treatment‐resistance is thought to rely on increased plasticity of the cancer cells—a mechanism whereby cancer cells alter their identity to adapt to changing environments or therapeutic pressures to create
Kira Furlano, Tina Keshavarzian, Nadine Biernath, Annika Fendler, Maria de Santis, Joachim Weischenfeldt, Mathieu Lupien   +6 more
wiley   +1 more source

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population‐based study in the Netherlands

International Journal of Cancer, EarlyView.
What's New? A range of treatment options exist for metastatic esophageal (EC) and gastric cancer (GC). Which modalities or combination thereof are optimal for these malignancies, however, remains uncertain. Here, the authors examined differences in systemic treatment for metastatic EC and GC across hospitals in the Netherlands.
Julie F. M. Geerts, Pauline A. J. Vissers, Bianca Mostert, Bas P. L. Wijnhoven, Brigitte C. M. Haberkorn, Marie‐Paule G. F. Anten, Camiel Rosman, Geert‐Jan Creemers, Harm Westdorp, Maurice J. C. van der Sangen, Rob H. A. Verhoeven, Grard A. P. Nieuwenhuijzen   +11 more
wiley   +1 more source

Primary Mesenteric Malignant Mixed Mesodermal (Müllerian) Tumor with Neuroendocrine Differentiation [PDF]

, 2001
Kristof Cokelaere, P. Michielsen, Robin Vos, Raf Sciot   +3 more
openalex   +1 more source

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

International Journal of Cancer, EarlyView.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li, Yijin Yu, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao   +7 more
wiley   +1 more source

Interleukin-6- and Cyclic AMP-Mediated Signaling Potentiates Neuroendocrine Differentiation of LNCaP Prostate Tumor Cells [PDF]

, 2001
Paul D. Deeble, Daniel J. Murphy, Sarah J. Parsons, Michael Cox   +3 more
openalex   +1 more source